Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Reinhardt

Showing results (161-170 of 236) with videos related to

Pageof 24
Sort By:
JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Leukemia|November 4, 2021
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trialLisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, et al.
Bone Marrow Transplantation|October 18, 2024
Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Cancer Discovery|September 20, 2018
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of OriginDian Yang, Sarah K Denny, Peyton G Greenside, et al.
Nature Communications|April 7, 2021
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesChristina M Bebber, Emily S Thomas, Jenny Stroh, et al.
Breast Cancer Research : BCR|June 17, 2022
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerLeonie Ratz, Chiara Brambillasca, Leandra Bartke, et al.
Blood|November 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAJan-Michel Heger, Julia Mattlener, Jessica Schneider, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Pageof 24

Showing results (161-170 of 236) with videos related to

Sort By:
Pageof 24
JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Leukemia|November 4, 2021
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trialLisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, et al.
Bone Marrow Transplantation|October 18, 2024
Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Cancer Discovery|September 20, 2018
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of OriginDian Yang, Sarah K Denny, Peyton G Greenside, et al.
Nature Communications|April 7, 2021
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesChristina M Bebber, Emily S Thomas, Jenny Stroh, et al.
Breast Cancer Research : BCR|June 17, 2022
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerLeonie Ratz, Chiara Brambillasca, Leandra Bartke, et al.
Blood|November 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAJan-Michel Heger, Julia Mattlener, Jessica Schneider, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Pageof 24